title: First report of a Pseudomonas aeruginosa clinical isolate co-harbouring KPC-2 and IMP-18 carbapenemases.
authors.forename: Teresa
authors.initials: T
authors.lastname: Martínez
authors.forename: Guillermo J
authors.initials: GJ
authors.lastname: Vázquez
authors.forename: Edna E
authors.initials: EE
authors.lastname: Aquino
authors.forename: Ramón
authors.initials: R
authors.lastname: Ramírez-Ronda
authors.forename: Iraida E
authors.initials: IE
authors.lastname: Robledo
mesh_terms: D000368:Aged; D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use; D024901:Drug Resistance, Multiple, Bacterial; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D008826:Microbial Sensitivity Tests / Q000379:methods; D016133:Polymerase Chain Reaction; D011552:Pseudomonas Infections / Q000188:drug therapy / Q000382:microbiology; D011550:Pseudomonas aeruginosa / Q000187:drug effects / Q000201:enzymology* / Q000235:genetics / Q000302:isolation & purification; D017422:Sequence Analysis, DNA; D001618:beta-Lactamases / Q000235:genetics
chemical_list: D000900:Anti-Bacterial Agents; C491478:beta-lactamase KPC-2; D001618:beta-Lactamases; C527279:beta-lactamase IMP-18, Pseudomonas aeruginosa